We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+14.62%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$1.92B
AUM Growth
+$361M
Cap. Flow
+$143M
Cap. Flow %
7.41%
Top 10 Hldgs %
38.22%
Holding
280
New
28
Increased
115
Reduced
75
Closed
14

Top Buys

Rank Stock Value
1
SRLN icon
State Street Blackstone Senior Loan ETF
SRLN
+$82.3M
2
JHML icon
John Hancock Multifactor Large Cap ETF
JHML
+$50.9M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$26.1M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$17.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12.2M

Top Sells

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$76.5M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$12M
3
SPDW icon
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
+$7.08M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$2.77M
5
EOG icon
EOG Resources
EOG
+$2.01M

Sector Composition

Rank Sector Weight
1 Technology 10.55%
2 Healthcare 6.61%
3 Financials 5.22%
4 Industrials 4.87%
5 Communication Services 3.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SDY icon
251
State Street SPDR S&P Dividend ETF
SDY
$23.6B
$212K 0.01%
+2,006
New +$203K
AMT icon
252
American Tower
AMT
$80.6B
$211K 0.01%
940
-52
-5% -$12.1K
VALE icon
253
Vale
VALE
$62B
$211K 0.01%
+12,568
New +$167K
IWB icon
254
iShares Russell 1000 ETF
IWB
$49B
$208K 0.01%
+982
New +$196K
FXB icon
255
Invesco CurrencyShares British Pound Sterling Trust
FXB
$64.5M
$205K 0.01%
+1,550
New +$198K
CALA
256
DELISTED
Calithera Biosciences, Inc
CALA
$196K 0.01%
1,999
+234
+13% +$20.5K
IRWD icon
257
Ironwood Pharmaceuticals
IRWD
$728M
$160K 0.01%
14,007
– –
MRNS
258
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$149K 0.01%
12,250
+1,000
+9% +$13.9K
NAK
259
Northern Dynasty Minerals
NAK
$818M
$101K 0.01%
312,865
-57,000
-15% -$41.2K
AGRX
260
DELISTED
Agile Therapeutics
AGRX
$86K ﹤0.01%
15
– –
ASX icon
261
ASE Group
ASX
$80.7B
$81K ﹤0.01%
13,925
– –
RGLS
262
DELISTED
Regulus Therapeutics
RGLS
$74K ﹤0.01%
5,451
+3,051
+127% +$22.4K
ITRM
263
DELISTED
Iterum Therapeutics
ITRM
$71K ﹤0.01%
+4,800
New +$56.2K
ADMA icon
264
ADMA Biologics
ADMA
$2.03B
$69K ﹤0.01%
35,309
+1,809
+5% +$3.8K
RBBN icon
265
Ribbon Communications
RBBN
$373M
$66K ﹤0.01%
10,030
– –
ALNA
266
DELISTED
Allena Pharmaceuticals
ALNA
$13K ﹤0.01%
10,000
-1,289
-11% -$1.8K
AWRE icon
267
Aware
AWRE
$26.2M
– –
-10,117
Closed -$27K
BABA icon
268
Alibaba
BABA
$305B
– –
-785
Closed -$231K
HBAN icon
269
Huntington Bancshares
HBAN
$35.1B
– –
-10,076
Closed -$92K
LQD icon
270
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
– –
-568,045
Closed -$76.5M
RF icon
271
Regions Financial
RF
$26.9B
– –
-11,502
Closed -$133K
SHV icon
272
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
– –
-6,114
Closed -$677K
IMMU
273
DELISTED
Immunomedics Inc
IMMU
– –
-4,150
Closed -$353K
AAC
274
DELISTED
AAC Holdings
AAC
– –
-45,454
Closed -$1K
UN
275
DELISTED
Unilever NV New York Registry Shares
UN
– –
-4,060
Closed -$246K
8 9 10
11
12

Similar funds

DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Grimes & Company's Q4 2020 Portfolio in Review

As of Q4 2020, Grimes & Company held 280 positions worth $1.92B, up 23% from $1.56B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Grimes & Company deployed $143M of net new capital in Q4 2020, opening 28 new positions and adding to 115 existing holdings. Its largest new stake was Alphabet (Google) Class A: 144,620 shares worth $12.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $12M trimmed.

  • Grimes & Company's largest Q4 2020 buy was Alphabet (Google) Class A: 144,620 shares worth $12.7M.
  • Grimes & Company added most to State Street Blackstone Senior Loan ETF in Q4 2020, an estimated $82.3M increase.
  • Grimes & Company's biggest Q4 2020 reduction was Alphabet (Google) Class C, cutting an estimated $12M.
  • Grimes & Company fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, selling an estimated $76.5M.
  • Grimes & Company's ten largest holdings make up 38% of its $1.92B portfolio in Q4 2020.
  • Grimes & Company opened 28 new positions and closed 14 in Q4 2020.
  • Grimes & Company's portfolio value rose 23% quarter-over-quarter to $1.92B.

Based on Grimes & Company's 13F filing for Q4 2020, filed 2 Feb 2021.